TG Therapeutics, Inc

(NASDAQ:TGTX)

Latest On TG Therapeutics, Inc (TGTX):

Date/Time Type Description Signal Details
2023-05-06 07:44 ESTNewsTG Therapeutics' Stock Surge: Exploring The Factors And Exercising Caution (Rating Upgrade)N/A
2023-05-02 02:37 ESTNewsTG Therapeutics jumps 19% to hit 52-week high after Q1 beat (update)N/A
2023-05-01 14:23 ESTNewsTG Therapeutics GAAP EPS of -$0.28 beats by $0.07, revenue of $7.8M beats by $4.42MN/A
2023-05-01 14:23 ESTNewsTG Therapeutics slips despite Q1 beatN/A
2023-05-01 14:22 ESTNewsTG Therapeutics, Inc. (TGTX) Q1 2023 Earnings Call TranscriptN/A
2023-04-29 00:22 ESTNewsTG Therapeutics: A Plethora Of Good News, Strong Revenues ExpectedN/A
2023-04-27 23:34 ESTNewsTG Therapeutics gains after reimbursement win for multiple sclerosis therapyN/A
2023-04-11 19:18 ESTNewsTG Therapeutics extends rally to hit 52-week high after B. Riley commentsN/A
2023-04-11 19:18 ESTNewsHot Stocks: TLRY drops on earnings; MARA, MSTR, RIOT, COIN boosted by crypto rise; PSMT gains; MRNA fallsN/A
2023-04-11 04:01 ESTNewsTG Therapeutics jumps 22% as Cantor cites strong Briumvi salesN/A
2023-03-31 11:03 ESTNewsTG Therapeutics' multiple sclerosis drug Briumvi gets EMA panel backingN/A
2023-03-22 17:59 ESTNewsTG Therapeutics' Briumvi Has Potential For Growth In A Crowded MarketN/A
2023-03-20 19:43 ESTNewsTG Therapeutics: That ICER Report Doesn't Bother MeN/A
2023-03-09 23:16 ESTNewsTG Therapeutics’ price for multiple sclerosis therapy is not low enough - ICERN/A
2023-03-01 01:53 ESTNewsTG Therapeutics, Inc. (TGTX) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 10:24 ESTNewsTG Therapeutics GAAP EPS of -$0.39 misses by $0.14, revenue of $0.08M misses by $1.52MN/A
2023-02-27 20:17 ESTNewsTG Therapeutics Q4 2022 Earnings PreviewN/A
2023-02-23 20:12 ESTNewsTG Therapeutics' Briumvi: A Tough Sell For Multiple Sclerosis Treatment MarketN/A
2023-02-07 11:09 ESTNewsTG Therapeutics up as Cantor sees a “strong launch” for multiple sclerosis therapyN/A
2023-02-01 21:47 ESTNewsTG Therapeutics: Strategy After Briumvi LaunchN/A
2023-01-26 12:41 ESTNewsTG Therapeutics launches newly approved multiple sclerosis therapyN/A
2023-01-11 14:59 ESTNewsTG Therapeutics adds 10% to extend gains after insider purchaseN/A
2023-01-02 17:51 ESTNewsTG Therapeutics: Ramifications Of Briumvi ApprovalN/A
2022-12-29 23:50 ESTNewsTG Therapeutics surges as focus turns to launch of new multiple sclerosis therapyN/A
2022-12-28 18:27 ESTNewsTG Therapeutics jumps 19% as FDA approves multiple sclerosis therapyN/A
2022-12-24 22:09 ESTNewsStocks To Watch: Nio, Tesla And Hopes For A Santa Clause RallyN/A
2022-12-17 21:07 ESTNewsIt's almost 2023, but here are the drugs the FDA could approve before the end of the yearN/A
2022-12-15 16:42 ESTNewsTG Therapeutics: Ublituximab Could Achieve $1 Billion In Annual Sales By Year-End 2024N/A
2022-12-14 23:31 ESTNewsTG Therapeutics: Would Santa Deliver An Early Present?N/A
2022-11-13 05:29 ESTNewsTG Therapeutics (TGTX) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 23:59 ESTNewsTG Therapeutics GAAP EPS of -$0.26 beats by $0.07, revenue of $0.09M misses by $1.61MN/A
2022-11-10 23:59 ESTNewsTG Therapeutics jumps 56% amid FDA labeling talks for multiple sclerosis therapyN/A
2022-10-09 13:35 ESTNewsTG Therapeutics: Elucidating The Upcoming BinaryN/A
2022-09-21 15:15 ESTNewsTG Therapeutics: We Are Just Hanging In ThereN/A
2022-08-25 19:03 ESTNewsTG Therapeutics announces peer-reviewed publication of multiple sclerosis phase 3 trialsN/A
2022-08-09 08:40 ESTNewsTG Therapeutics stock soars 18% on Q2 beat as net loss narrows; eyes MS drug win by year-endN/A
2022-08-09 08:40 ESTNewsTG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 09:01 ESTNewsTG Therapeutics GAAP EPS of -$0.30 beats by $0.17, revenue of $0.6M beats by $0.42MN/A
2022-08-06 00:27 ESTNewsTG Therapeutics Q2 2022 Earnings PreviewN/A
2022-07-09 02:04 ESTNewsTG Therapeutics And Ublituximab: From Icing To LifelineN/A
2022-06-01 21:32 ESTNewsTG Therapeutics slips as FDA withdraws approval for cancer drugN/A
2022-05-31 12:26 ESTNewsTG Therapeutics announces delay in FDA review for multiple sclerosis drugN/A
2022-05-21 18:22 ESTNewsTG Therapeutics initiated at BofA with a bearish view on multiple sclerosis drugN/A
2022-04-22 18:32 ESTNewsTG Therapeutics: Can The Company Successfully Turn Around?N/A
2022-04-18 21:06 ESTNewsTG Therapeutics: I May Double Down AgainN/A
2022-04-18 21:06 ESTNewsTG Therapeutics extends losses as H.C. Wainwright slashes target on Ukoniq setbackN/A
2022-04-18 06:43 ESTNewsTG Therapeutics stock falls 24% as it withdraws Ukoniq from sale, pulls filing with FDAN/A
2022-03-03 18:32 ESTNewsTG Therapeutics stock falls as FDA extends review of blood cancer drug comboN/A
2022-03-01 13:48 ESTNewsTG Therapeutics GAAP EPS of -$0.70 misses by $0.08, revenue of $2.32M beats by $0.08MN/A
2022-03-01 13:47 ESTNewsTG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q4 2021 Results - Earnings Call TranscriptN/A

About TG Therapeutics, Inc (TGTX):

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbralisib, an oral inhibitor of PI3K-delta and CK1-epsilon for the treatment of CLL, marginal zone lymphoma, and follicular lymphoma. The company also develops Cosibelimab, a human monoclonal antibody of IgG1 subtype that binds to programmed death-ligand 1 (PD-L1) and blocks its interactions with PD-1 and B7.1 receptors; TG-1701 is an orally available and covalently-bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK compared to ibrutinib in in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. In addition, it has various licensed preclinical programs for BET, interleukin-1 receptor associated kinase-4, and GITR; and collaboration agreements with Checkpoint Therapeutics, Inc., Jiangsu Hengrui Medicine Co., Novimmune SA, Ligand Pharmaceuticals Incorporated, and Jubilant Biosys. The company has strategic alliances with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Rhizen Pharmaceuticals, S A. The company is headquartered in New York, New York.

See Advanced Chart

General

  • Name TG Therapeutics, Inc
  • Symbol TGTX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 272
  • Last Split Factor100:5625
  • Last Split Date2012-04-30
  • Fiscal Year EndDecember
  • IPO Date1995-12-14
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.tgtherapeutics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 36580.51
  • Price/Book (Most Recent Quarter) 13.05
  • Enterprise Value Revenue 40882.96
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.06
  • Next Year EPS Estimate -$0.80
  • Next Quarter EPS Estimate -$0.50
  • Operating Margin -179996%
  • Return on Assets -43%
  • Return on Equity -100%
  • Revenue 152000
  • Earnings Per Share -$1.96
  • Revenue Per Share $0
  • Gross Profit 152000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 6.47 billion
  • EBITDA -158616992
  • PE Ratio 37.85
  • Analyst Target Price $75.33
  • Book Value Per Share $4.00
View More

Share Statistics

  • Shares Outstanding 137.81 million
  • Shares Float 120.36 million
  • % Held by Insiders 713%
  • % Held by Institutions 67.24%
  • Shares Short 11.84 million
  • Shares Short Prior Month 11.76 million
  • Short Ratio 8
  • Short % of Float 10%
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 2.13
  • 52 Week High $56.74
  • 52 Week Low $7.12
  • 50 Day Moving Average 46.97
  • 200 Day Moving Average 37.82
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

TG Therapeutics, Inc (TGTX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

TG Therapeutics, Inc (TGTX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$38000-$0.72-$0.58-23.78%
2020-09-302020-11-09$N/A-$0.73-$0.41-76.76%
2020-06-302020-08-10$N/A-$0.47-$0.34-39.05%
2020-03-312020-05-11$38000-$0.48-$0.36-34.08%
2019-12-312020-03-02$38000-$0.44-$0.42-5.39%
2019-09-302019-11-12$38000-$0.69-$0.34-104.44%
2019-06-302019-08-09$38000-$0.42-$0.444.55%
2019-03-312019-05-10$38000-$0.43-$0.441.15%
2018-12-312019-03-01$38000-$0.69-$0.44-55.41%
2018-09-302018-11-09$38000-$0.43-$0.5420.37%
2018-06-302018-08-07$38000-$0.59-$0.53-12.38%
2018-03-312018-05-08$38000-$0.59-$0.44-34.09%
2017-12-312018-03-08$38000-$0.46-$0.44-4.14%
2017-09-302017-11-08$38000-$0.48-$0.43-11.63%
2017-06-302017-08-09$38000-$0.45-$0.43-5.26%
2017-03-312017-05-05$38000-$0.52-$0.41-27.45%
2016-12-312017-03-10$38000-$0.48-$0.36-33.33%
2016-09-302016-11-07$38000-$0.50-$0.31-61.29%
2016-06-302016-08-08$38000-$0.33-$0.29-15.79%
2016-03-312016-05-10$38000-$0.28-$0.3621.5%
2015-12-312016-03-07$38000-$0.37-$0.32-16.83%
2015-09-302015-11-09$38000-$0.28-$0.3417.65%
2015-06-302015-08-10$38000-$0.38-$0.30-26.67%
2015-03-312015-05-04$38000-$0.39-$0.33-18.18%
2014-12-312015-03-11$38000-$0.48-$0.26-84.62%
2014-09-302014-11-10$38000-$0.51-$0.32-59.38%
2014-06-302014-07-21$38000-$0.32-$0.24-33.33%
2014-03-312014-05-12$38000-$0.25-$0.18-38.89%
2013-12-312014-03-05$38000-$0.19-$0.17-11.76%
2013-09-302013-11-11$38000-$0.16-$0.2227.27%
2013-06-302013-08-01$38000-$0.29-$0.16-81.25%
2013-03-312013-05-14$38000-$0.17-$0.15-13.33%
2012-12-312013-03-12$19000-$0.12-$0.137.69%
2012-09-302012-11-08$N/A-$0.16-$0.12-33.33%
2012-06-302012-08-09$N/A-$0.16-$0.06-166.67%
2012-03-312012-05-21$N/A-$2.03
2011-09-302011-11-14$N/A-$9.05
2011-06-302011-08-15$N/A-$64.63
2011-03-312011-05-23$N/A$84.58
2010-12-312011-03-02$N/A$9.18
2010-09-302010-11-15$N/A$0.96
2010-06-302010-08-16$N/A$43.21
2010-03-312010-05-24$N/A-$54.27
2009-12-312010-03-03$N/A-$8.88
2009-09-302009-11-16$N/A-$16.57
2009-06-302009-08-14$N/A-$55.45
2009-03-312009-05-19$N/A-$30.34
2008-12-312009-02-25$N/A$5.06
2008-09-302008-12-03$N/A-$55.53
2008-06-302008-08-19$N/A-$56.64
2008-03-312008-05-20$N/A-$62.10
2007-09-302007-11-14$N/A-$112.50-$28.12-300.07%
2007-06-302007-07-09$N/A-$112.50-$84.37-33.34%
2007-03-312007-05-15$N/A-$119.73
2006-09-302006-11-14$N/A-$84.37-$84.370%
2006-06-302006-08-14$N/A-$112.50-$112.500%
2006-03-312006-05-15$N/A-$140.62-$140.620%
2005-09-302005-09-30$N/A-$118.85
2005-06-302005-06-30$N/A-$934.25
2005-03-312005-03-31$N/A-$152.43
2004-12-312004-12-31$N/A-$196.87
2004-09-302004-09-30$N/A-$240.39
2004-06-302004-06-30$N/A-$109.61
2004-03-312004-03-31$N/A-$140.65
2003-12-312003-12-31$N/A-$225.00
2003-09-302003-09-30$N/A-$391.61
2003-06-302003-06-30$N/A-$93.46
2003-03-312003-03-31$N/A-$91.67
2002-09-302002-09-30$N/A-$507.41
2002-06-302002-06-30$N/A$24.21
2002-03-312002-03-31$N/A-$552.10
2001-09-302001-09-30$N/A-$1,528.45
2001-06-302001-06-30$-2712000-$4,513.55
2001-03-312001-03-31$2.71 million$1,855.58
2000-09-302000-09-30$1.07 million-$2,621.34
2000-06-302000-06-30$1.44 million-$7,888.48
2000-03-312000-03-31$925000-$5,766.57
1999-09-301999-09-30-$986.48
1999-06-301999-06-30-$1,929.43
1999-03-311999-03-31-$2,666.06
1998-09-301998-09-30-$5,140.91
1998-06-301998-06-30$695.14
1998-03-311998-03-31-$9,885.89

TG Therapeutics, Inc (TGTX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

TG Therapeutics, Inc (TGTX) Chart:

TG Therapeutics, Inc (TGTX) News:

Below you will find a list of latest news for TG Therapeutics, Inc (TGTX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

TG Therapeutics, Inc (TGTX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-07-17300CALL0 00TRUE00
2026-07-17310CALL0 00TRUE00
2026-07-17320CALL0 00TRUE00
2026-07-17330CALL0 00TRUE00
2026-07-17340CALL0 00TRUE00
2026-07-17350CALL0 60TRUE00
2026-07-173616.6CALL0 1776.59TRUE00
2026-07-17370CALL0 210TRUE00
2026-07-173814.99CALL1 250TRUE14.990
2026-07-173914.07CALL6 920TRUE14.070
2026-07-174013.55CALL15 20765.46TRUE0.410.03
2026-07-174111.7CALL1 2838.26TRUE11.70
2026-07-174210.7CALL5 840TRUE10.70
2026-07-17439.95CALL17 2700TRUE9.950
2026-07-17449.17CALL1 25651.7TRUE9.170
2026-07-17458.4CALL16 27750.87TRUE0.90.12
2026-07-17466.96CALL7 2358.05TRUE6.960
2026-07-17470CALL0 3147.02TRUE00
2026-07-17486.2CALL15 39746.77TRUE0.750.14
2026-07-17494.93CALL1 3749.82TRUE-0.07-0.01
2026-07-17505.1CALL208 113555.12TRUE0.770.18
2026-07-17552.55CALL511 167750.96FALSE0.470.23
2026-07-17601.13CALL441 271854.77FALSE0.030.03
2026-07-17650.62CALL86 26455.35FALSE-0.08-0.11
2026-07-17700.35CALL225 37163.12FALSE-0.05-0.13
2026-07-17750.21CALL17 38677.37FALSE-0.04-0.16
2026-07-17800.18CALL14 075.32FALSE0.180
2026-07-17300PUT0 0144.83FALSE00
2026-07-17310PUT0 0137.95FALSE00
2026-07-17320PUT0 1132.69FALSE00
2026-07-17330PUT0 92135.02FALSE00
2026-07-17340PUT0 1119.78FALSE00
2026-07-17350PUT0 12986.24FALSE00
2026-07-17360.1PUT10 5073.52FALSE0.10
2026-07-17370.05PUT0 1471.84FALSE00
2026-07-17380.12PUT0 2769.69FALSE00
2026-07-17390.15PUT10 8365.18FALSE0.150
2026-07-17400.37PUT8 23460.75FALSE0.110.42
2026-07-17410.2PUT0 302659.89FALSE00
2026-07-17420PUT0 7460.91FALSE00
2026-07-17430PUT0 1060.6FALSE00
2026-07-17440PUT0 1360.31FALSE00
2026-07-17450.74PUT8 9256.81FALSE0.070.1
2026-07-17460.87PUT0 6358.06FALSE00
2026-07-17470.99PUT0 3155.03FALSE00
2026-07-17481.3PUT27 48253.34FALSE-0.2-0.13
2026-07-17491.75PUT0 12053.08FALSE00
2026-07-17501.8PUT28 5848.1FALSE00
2026-07-17554.51PUT22 1653.72TRUE-0.29-0.06
2026-07-17600PUT0 064.67TRUE00
2026-07-17650PUT0 069.98TRUE00
2026-07-17700PUT0 071.48TRUE00
2026-07-17750PUT0 090.11TRUE00
2026-07-17800PUT0 093.57TRUE00
2026-08-21150CALL0 650TRUE00
2026-08-21200CALL0 210TRUE00
2026-08-21210CALL0 00TRUE00
2026-08-21220CALL0 730TRUE00
2026-08-21230CALL0 40TRUE00
2026-08-21240CALL0 10TRUE00
2026-08-21250CALL0 700TRUE00
2026-08-21260CALL0 1520TRUE00
2026-08-212725.1CALL0 480TRUE00
2026-08-21280CALL0 290TRUE00
2026-08-21290CALL0 4464.43TRUE00
2026-08-213023.15CALL5 940TRUE23.150
2026-08-21310CALL0 160TRUE00
2026-08-21320CALL0 380TRUE00
2026-08-213319.8CALL0 1046.03TRUE00
2026-08-21340CALL0 190TRUE00
2026-08-213518.45CALL2 72234.01TRUE-0.61-0.03
2026-08-21360CALL0 6049.56TRUE00
2026-08-21370CALL0 9059.79TRUE00
2026-08-21380CALL0 11361.38TRUE00
2026-08-21390CALL0 5750.36TRUE00
2026-08-214013.54CALL7 54957.99TRUE-0.61-0.04
2026-08-214114.15CALL4 13854.1TRUE14.150
2026-08-214212.2CALL20 14757.17TRUE12.20
2026-08-21430CALL0 14456.13TRUE00
2026-08-214410.27CALL10 32652TRUE10.270
2026-08-214510.4CALL23 65351.42TRUE0.450.05
2026-08-21460CALL0 15055.84TRUE00
2026-08-21478.36CALL25 2554.89TRUE8.360
2026-08-21488.44CALL23 9560.92TRUE-0.12-0.01
2026-08-21490CALL0 2653.93TRUE00
2026-08-21506.26CALL58 78358.09TRUE-0.81-0.11
2026-08-21554.27CALL422 143055.39FALSE0.270.07
2026-08-21602.6CALL68 148258.74FALSE-0.38-0.13
2026-08-21651.75CALL8 4259.54FALSE-0.36-0.17
2026-08-21700CALL0 065.13FALSE00
2026-08-21750CALL0 075.45FALSE00
2026-08-21800CALL0 064.38FALSE00
2026-08-21150PUT0 78148.23FALSE00
2026-08-21200PUT0 60165.15FALSE00
2026-08-21210PUT0 1165.26FALSE00
2026-08-21220PUT0 15165.7FALSE00
2026-08-21230PUT0 6158.51FALSE00
2026-08-21240PUT0 43151.65FALSE00
2026-08-21250PUT0 30145.08FALSE00
2026-08-21260PUT0 22138.77FALSE00
2026-08-21270PUT0 21132.72FALSE00
2026-08-21280PUT0 70126.88FALSE00
2026-08-21290PUT0 1378.14FALSE00
2026-08-21300PUT0 4176.37FALSE00
2026-08-21310PUT0 1272.58FALSE00
2026-08-21320PUT0 9106.89FALSE00
2026-08-21330.44PUT0 1169.99FALSE00
2026-08-21340PUT0 568.9FALSE00
2026-08-21350.4PUT0 33971.56FALSE00
2026-08-21360PUT0 3862.71FALSE00
2026-08-21370PUT0 4263.91FALSE00
2026-08-21380.6PUT0 2664.96FALSE00
2026-08-21390PUT0 3159.68FALSE00
2026-08-21400.98PUT0 13661.29FALSE00
2026-08-21410PUT0 078.71FALSE00
2026-08-21420PUT0 877.52FALSE00
2026-08-21430PUT0 4866.95FALSE00
2026-08-21440PUT0 263.74FALSE00
2026-08-21451.77PUT0 5851.1FALSE00
2026-08-21460PUT0 064.07FALSE00
2026-08-21470PUT0 063.1FALSE00
2026-08-21482.9PUT0 5370.24FALSE00
2026-08-21493.2PUT0 16457.74FALSE00
2026-08-21503.7PUT257 33650.78FALSE-0.3-0.08
2026-08-21556.33PUT0 5958.71TRUE00
2026-08-21600PUT0 155.78TRUE00
2026-08-21650PUT0 062.74TRUE00
2026-08-21700PUT0 065.64TRUE00
2026-08-21750PUT0 070.26TRUE00
2026-08-21800PUT0 073.56TRUE00
2026-11-20200CALL0 375.01TRUE00
2026-11-20220CALL0 073.64TRUE00
2026-11-20230CALL0 065.53TRUE00
2026-11-20240CALL0 068.29TRUE00
2026-11-202528.27CALL0 30TRUE00
2026-11-20260CALL0 067.86TRUE00
2026-11-20270CALL0 867.99TRUE00
2026-11-20280CALL0 064.36TRUE00
2026-11-20290CALL0 2062.54TRUE00
2026-11-20300CALL0 34057.51TRUE00
2026-11-20310CALL0 061.47TRUE00
2026-11-20320CALL0 063.9TRUE00
2026-11-20330CALL0 561.58TRUE00
2026-11-20340CALL0 661.15TRUE00
2026-11-20350CALL0 1460.49TRUE00
2026-11-20360CALL0 160.41TRUE00
2026-11-20370CALL0 2160.08TRUE00
2026-11-20380CALL0 560.18TRUE00
2026-11-20390CALL0 756.89TRUE00
2026-11-204015.25CALL6 12359.63TRUE15.250
2026-11-20410CALL0 756.85TRUE00
2026-11-20420CALL0 258.84TRUE00
2026-11-20430CALL0 2154.93TRUE00
2026-11-204413.15CALL8 9557.37TRUE13.150
2026-11-204512.93CALL20 69255.74TRUE12.930
2026-11-20460CALL0 154.46TRUE00
2026-11-20470CALL0 14956.06TRUE00
2026-11-20480CALL0 5956.14TRUE00
2026-11-20490CALL0 37456.03TRUE00
2026-11-20509.44CALL13 48155.37TRUE-0.56-0.06
2026-11-20557.3CALL18 14555.15FALSE00
2026-11-20605.4CALL15 38755.42FALSE-0.03-0.01
2026-11-20654.1CALL19 555.29FALSE4.10
2026-11-20700CALL0 3855.08FALSE00
2026-11-20752.2CALL51 051.3FALSE2.20
2026-11-20801.5CALL58 053.09FALSE1.50
2026-11-20200PUT0 1118.8FALSE00
2026-11-20220PUT0 0109.37FALSE00
2026-11-20230PUT0 1104.67FALSE00
2026-11-20240PUT0 10100.8FALSE00
2026-11-20250PUT0 1097.07FALSE00
2026-11-20260PUT0 1796.22FALSE00
2026-11-20270PUT0 090FALSE00
2026-11-20280PUT0 386.63FALSE00
2026-11-20290PUT0 383.85FALSE00
2026-11-20300PUT0 114482.04FALSE00
2026-11-20310PUT0 077.98FALSE00
2026-11-20320PUT0 075.35FALSE00
2026-11-20330PUT0 1573.55FALSE00
2026-11-20340PUT0 070.95FALSE00
2026-11-20350PUT0 7269.11FALSE00
2026-11-20360PUT0 166.52FALSE00
2026-11-20370PUT0 064.63FALSE00
2026-11-20380PUT0 062.71FALSE00
2026-11-20390PUT0 1959.52FALSE00
2026-11-20402.3PUT3 5560.18FALSE2.30
2026-11-20410PUT0 059.45FALSE00
2026-11-20420PUT0 3259.6FALSE00
2026-11-20430PUT0 063.16FALSE00
2026-11-20440PUT0 065.04FALSE00
2026-11-20454PUT20 160.59FALSE40
2026-11-20464.2PUT2 3459.7FALSE-0.2-0.05
2026-11-20470PUT0 358.68FALSE00
2026-11-20486.03PUT0 158.36FALSE00
2026-11-20496PUT3 252.7FALSE60
2026-11-20500PUT0 158.44FALSE00
2026-11-20558.82PUT1 053.24TRUE8.820
2026-11-20600PUT0 157.41TRUE00
2026-11-20650PUT0 057.55TRUE00
2026-11-20700PUT0 058.26TRUE00
2026-11-20750PUT0 057.06TRUE00
2026-11-20800PUT0 058.1TRUE00
2027-01-151341.1CALL10 113122.26TRUE0.250.01
2027-01-15150CALL0 6920TRUE00
2027-01-15180CALL0 21768.04TRUE00
2027-01-152033CALL0 6900TRUE00
2027-01-152232.56CALL9 254739.07TRUE-0.14-0
2027-01-152529.25CALL14 62955.3TRUE-0.15-0.01
2027-01-152725.8CALL0 28758.22TRUE00
2027-01-153024.39CALL4 54962.55TRUE-0.28-0.01
2027-01-153223CALL60 22158.84TRUE230
2027-01-153520.35CALL4 140762.14TRUE0.350.02
2027-01-153719.85CALL0 38058.22TRUE00
2027-01-154017.3CALL4 287662.31TRUE1.30.08
2027-01-15410CALL0 3058.65TRUE00
2027-01-154214.47CALL0 13357.67TRUE00
2027-01-154315.57CALL0 857.42TRUE00
2027-01-15440CALL0 957.44TRUE00
2027-01-154513.8CALL2 160557.31TRUE-0.28-0.02
2027-01-15460CALL0 3457.04TRUE00
2027-01-154713.1CALL0 22457.01TRUE00
2027-01-15480CALL0 1158.95TRUE00
2027-01-154911.39CALL0 7455.87TRUE00
2027-01-155010.73CALL19 165355.48TRUE0.330.03
2027-01-15558.45CALL18 106254.86FALSE-0.05-0.01
2027-01-15606.6CALL13 179853.9FALSE0.10.02
2027-01-15655.15CALL12 1354.14FALSE-0.55-0.1
2027-01-15704CALL8 24653.4FALSE-0.12-0.03
2027-01-15753CALL3 053.32FALSE30
2027-01-15800CALL0 049.43FALSE00
2027-01-15130PUT0 4996.37FALSE00
2027-01-15150.36PUT0 184111.47FALSE00
2027-01-15180PUT0 74112.69FALSE00
2027-01-15200PUT0 17784.81FALSE00
2027-01-15220PUT0 32976.67FALSE00
2027-01-15250.59PUT0 223169.18FALSE00
2027-01-15270PUT0 12366.32FALSE00
2027-01-15300PUT0 106765.46FALSE00
2027-01-15321.27PUT3 3662.49FALSE1.270
2027-01-15351.7PUT2 167561.66FALSE1.70
2027-01-15372.1PUT0 3361.53FALSE00
2027-01-15403PUT0 96660.52FALSE00
2027-01-15410PUT0 063.25FALSE00
2027-01-15420PUT0 18066.82FALSE00
2027-01-15430PUT0 165.59FALSE00
2027-01-15440PUT0 065.85FALSE00
2027-01-15454.9PUT1 28764.46FALSE4.90
2027-01-15460PUT0 064.11FALSE00
2027-01-15470PUT0 058.99FALSE00
2027-01-15480PUT0 058.54FALSE00
2027-01-15490PUT0 057.98FALSE00
2027-01-15500PUT0 40857.99FALSE00
2027-01-15559.82PUT0 6956.99TRUE00
2027-01-15600PUT0 57554.45TRUE00
2027-01-15650PUT0 056.23TRUE00
2027-01-157020.68PUT0 1055.75TRUE00
2027-01-15750PUT0 055.9TRUE00
2027-01-15800PUT0 056TRUE00
2027-02-19400CALL0 057.76TRUE00
2027-02-19450CALL0 056.67TRUE00
2027-02-19500CALL0 055.53TRUE00
2027-02-19550CALL0 055.61FALSE00
2027-02-19600CALL0 055.54FALSE00
2027-02-19656.15CALL1 055.62FALSE6.150
2027-02-19700CALL0 054.06FALSE00
2027-02-19750CALL0 054.06FALSE00
2027-02-19400PUT0 059.37FALSE00
2027-02-19450PUT0 058.02FALSE00
2027-02-19500PUT0 056.67FALSE00
2027-02-19550PUT0 055.67TRUE00
2027-02-19600PUT0 055.38TRUE00
2027-02-19650PUT0 055.45TRUE00
2027-02-19700PUT0 055.27TRUE00
2027-02-19750PUT0 055.44TRUE00
2028-01-211539.8CALL0 44662.34TRUE00
2028-01-21200CALL0 16163.29TRUE00
2028-01-21230CALL0 21057.38TRUE00
2028-01-212531.84CALL10 17159.53TRUE0.840.03
2028-01-212829.2CALL0 760.22TRUE00
2028-01-213029CALL0 24360.61TRUE00
2028-01-213225.6CALL1 31661.21TRUE25.60
2028-01-21350CALL0 6757.36TRUE00
2028-01-213722.5CALL0 1660.48TRUE00
2028-01-214022.25CALL15 8659.94TRUE22.250
2028-01-21420CALL0 8359.57TRUE00
2028-01-214520.6CALL10 99159.01TRUE20.60
2028-01-215018.28CALL18 32358.35TRUE2.330.15
2028-01-215515.35CALL36 104456.16FALSE0.60.04
2028-01-216013.5CALL1 57155.81FALSE00
2028-01-216511.69CALL1 1054.17FALSE11.690
2028-01-217010.66CALL63 30954.69FALSE0.010
2028-01-21750CALL0 055.19FALSE00
2028-01-21808.18CALL4 054.42FALSE8.180
2028-01-21150PUT0 17286.64FALSE00
2028-01-21200PUT0 5065.49FALSE00
2028-01-21230PUT0 7373.34FALSE00
2028-01-21250PUT0 5469.97FALSE00
2028-01-21280PUT0 8058.81FALSE00
2028-01-21300PUT0 36358.23FALSE00
2028-01-21320PUT0 3460.83FALSE00
2028-01-21350PUT0 3458.64FALSE00
2028-01-21370PUT0 360.74FALSE00
2028-01-21400PUT0 4259.89FALSE00
2028-01-21427.8PUT0 7559.24FALSE00
2028-01-21450PUT0 6857.48FALSE00
2028-01-215011.8PUT0 12057.2FALSE00
2028-01-215514.35PUT0 1853.66TRUE00
2028-01-216016.95PUT0 2353.29TRUE00
2028-01-21650PUT0 156.03TRUE00
2028-01-217024PUT1 101952.85TRUE0.620.03
2028-01-21750PUT0 055.26TRUE00
2028-01-21800PUT0 053.99TRUE00

Latest TGTX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST987$4.135
Jun 13, 2022 7:59 PM EST93$4.14
Jun 13, 2022 7:59 PM EST1$4.14
Jun 13, 2022 7:59 PM EST10$4.14
Jun 13, 2022 7:59 PM EST200$4.135

TG Therapeutics, Inc (TGTX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm
2018-07-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1001316/000000000018021923/0000000000-18-021923-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000009375119000238/0000093751-19-000238-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000009375120000475/0000093751-20-000475-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000021545719006548/0000215457-19-006548-index.htm
2019-06-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000021545719008047/0000215457-19-008047-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000031506618001636/0000315066-18-001636-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000031506619001380/0000315066-19-001380-index.htm
2020-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000031506620001583/0000315066-20-001583-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000083423720008183/0000834237-20-008183-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000090266419001008/0000902664-19-001008-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000090266420001111/0000902664-20-001111-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920021910/0001104659-20-021910-index.htm
2020-05-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920058131/0001104659-20-058131-index.htm
2020-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920072021/0001104659-20-072021-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076543/0001104659-20-076543-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076544/0001104659-20-076544-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076545/0001104659-20-076545-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076546/0001104659-20-076546-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076547/0001104659-20-076547-index.htm
2020-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920080593/0001104659-20-080593-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm
2020-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000110465920092406/0001104659-20-092406-index.htm
2020-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920104436/0001104659-20-104436-index.htm
2019-05-31PX14A6GNotice of exempt solicitation submitted by non-managementhttps://www.sec.gov/Archives/edgar/data/1001316/000114036119010173/0001140361-19-010173-index.htm
2020-05-29PX14A6GNotice of exempt solicitation submitted by non-managementhttps://www.sec.gov/Archives/edgar/data/1001316/000114036120012674/0001140361-20-012674-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000114420419008306/0001144204-19-008306-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266118000780/0001172661-18-000780-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266119000823/0001172661-19-000823-index.htm
2019-03-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266119000927/0001172661-19-000927-index.htm
2020-01-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266120000001/0001172661-20-000001-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266120000786/0001172661-20-000786-index.htm
2018-06-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1001316/000119312518195773/0001193125-18-195773-index.htm
2018-07-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1001316/000119312518215834/0001193125-18-215834-index.htm
2019-03-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000131924419000034/0001319244-19-000034-index.htm
2020-01-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000131924420000018/0001319244-20-000018-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1001316/000155837020001897/0001558370-20-001897-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020001925/0001558370-20-001925-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020002992/0001558370-20-002992-index.htm
2020-03-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020002997/0001558370-20-002997-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1001316/000155837020004647/0001558370-20-004647-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1001316/000155837020004651/0001558370-20-004651-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020004722/0001558370-20-004722-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020005097/0001558370-20-005097-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020006304/0001558370-20-006304-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020006314/0001558370-20-006314-index.htm
2020-05-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020006630/0001558370-20-006630-index.htm
2020-05-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020006795/0001558370-20-006795-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020006811/0001558370-20-006811-index.htm
2020-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020007744/0001558370-20-007744-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020010225/0001558370-20-010225-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020012661/0001558370-20-012661-index.htm
2018-02-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418001025/0001654954-18-001025-index.htm
2018-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418002262/0001654954-18-002262-index.htm
2018-03-1510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1001316/000165495418002638/0001654954-18-002638-index.htm
2018-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004295/0001654954-18-004295-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004519/0001654954-18-004519-index.htm
2018-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004521/0001654954-18-004521-index.htm
2018-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004821/0001654954-18-004821-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495418005046/0001654954-18-005046-index.htm
2018-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006261/0001654954-18-006261-index.htm
2018-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006381/0001654954-18-006381-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006609/0001654954-18-006609-index.htm
2018-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006703/0001654954-18-006703-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006742/0001654954-18-006742-index.htm
2018-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006743/0001654954-18-006743-index.htm
2018-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006777/0001654954-18-006777-index.htm
2018-06-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006935/0001654954-18-006935-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007116/0001654954-18-007116-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007117/0001654954-18-007117-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007118/0001654954-18-007118-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007119/0001654954-18-007119-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007120/0001654954-18-007120-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007121/0001654954-18-007121-index.htm
2018-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007267/0001654954-18-007267-index.htm
2018-07-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm
2018-07-09S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1001316/000165495418007460/0001654954-18-007460-index.htm
2018-07-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007816/0001654954-18-007816-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418008559/0001654954-18-008559-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495418008750/0001654954-18-008750-index.htm
2018-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418010436/0001654954-18-010436-index.htm
2018-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418011171/0001654954-18-011171-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418012263/0001654954-18-012263-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495418012303/0001654954-18-012303-index.htm
2018-12-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418013524/0001654954-18-013524-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419000085/0001654954-19-000085-index.htm
2019-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419000641/0001654954-19-000641-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419002047/0001654954-19-002047-index.htm
2019-02-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419002091/0001654954-19-002091-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1001316/000165495419002189/0001654954-19-002189-index.htm
2019-03-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419002274/0001654954-19-002274-index.htm
2019-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419002276/0001654954-19-002276-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419003766/0001654954-19-003766-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005036/0001654954-19-005036-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005037/0001654954-19-005037-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005419/0001654954-19-005419-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005592/0001654954-19-005592-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419005680/0001654954-19-005680-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007297/0001654954-19-007297-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007359/0001654954-19-007359-index.htm
2019-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007706/0001654954-19-007706-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007935/0001654954-19-007935-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419009109/0001654954-19-009109-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419009176/0001654954-19-009176-index.htm
2019-08-30S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1001316/000165495419010203/0001654954-19-010203-index.htm
2019-09-05RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010400/0001654954-19-010400-index.htm
2019-09-05S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010402/0001654954-19-010402-index.htm
2019-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010620/0001654954-19-010620-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010885/0001654954-19-010885-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010886/0001654954-19-010886-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010888/0001654954-19-010888-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010890/0001654954-19-010890-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010891/0001654954-19-010891-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419012023/0001654954-19-012023-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419012611/0001654954-19-012611-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419012751/0001654954-19-012751-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419013703/0001654954-19-013703-index.htm
2019-12-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419014167/0001654954-19-014167-index.htm
2019-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419014209/0001654954-19-014209-index.htm
2018-07-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1001316/999999999518001856/9999999995-18-001856-index.htm
2018-04-30CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1001316/999999999718005345/9999999997-18-005345-index.htm
2018-09-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1001316/999999999718007926/9999999997-18-007926-index.htm

TG Therapeutics, Inc (TGTX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of TG Therapeutics, Inc (TGTX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 713%
Institutional Ownership: 6724%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-17WILLIAM JAMES KENNEDYDirectorBuy27,048.00102,378.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010886/0001654954-19-010886-index.htm
2020-06-22WILLIAM JAMES KENNEDYDirectorBuy15,000.00109,633.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm
2018-06-26MICHAEL S WEISSCEO and PresidentBuy1,018,011.0011,648,805.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007119/0001654954-18-007119-index.htm
2018-06-26Kenneth HobermanDirectorBuy15,000.00116,905.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007121/0001654954-18-007121-index.htm
2018-06-26Yann EchelardDirectorBuy15,000.00117,068.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007116/0001654954-18-007116-index.htm
2018-06-26Laurence N CharneyDirectorBuy15,000.00118,949.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007267/0001654954-18-007267-index.htm
2019-09-17DANIEL HUMEDirectorBuy27,048.00119,507.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010885/0001654954-19-010885-index.htm
2018-06-26MARK SCHOENEBAUMDirectorBuy15,000.00125,949.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007117/0001654954-18-007117-index.htm
2020-09-09RA CAPITAL MANAGEMENT, L.P.10% Share HolderSell158,589.0025.814,092,738.0412,629,868.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920104436/0001104659-20-104436-index.htm
2019-06-13MICHAEL S WEISSCEO and PresidentBuy1,179,380.0012,828,185.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419007359/0001654954-19-007359-index.htm
2019-06-26MICHAEL S WEISSCEO and PresidentBuy50,000.007.04351,750.0012,878,185.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419007706/0001654954-19-007706-index.htm
2020-06-22DANIEL HUMEDirectorBuy15,000.00134,507.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076546/0001104659-20-076546-index.htm
2019-09-17Kenneth HobermanDirectorBuy27,048.00143,953.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010891/0001654954-19-010891-index.htm
2019-09-17Yann EchelardDirectorBuy27,048.00144,116.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010888/0001654954-19-010888-index.htm
2020-06-22MICHAEL S WEISSCEO and PresidentBuy1,556,029.0014,434,214.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076547/0001104659-20-076547-index.htm
2019-09-17Laurence N CharneyDirectorBuy27,048.00145,997.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010890/0001654954-19-010890-index.htm
2020-06-22Kenneth HobermanDirectorBuy15,000.00158,953.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076545/0001104659-20-076545-index.htm
2020-06-22Yann EchelardDirectorBuy15,000.00159,116.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076544/0001104659-20-076544-index.htm
2020-06-22Laurence N CharneyDirectorBuy15,000.00160,997.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076543/0001104659-20-076543-index.htm
2019-07-01Sean A PowerCFO, Secretary and TreasurerSell17,654.008.47149,529.38383,338.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419007935/0001654954-19-007935-index.htm
2019-01-02Sean A PowerCFO, Secretary and TreasurerSell37,275.004.13153,945.75400,992.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419000085/0001654954-19-000085-index.htm
2020-07-16Sean A PowerCFO, Secretary and TreasurerBuy50,000.00433,338.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm
2018-07-03Sean A PowerCFO, Secretary and TreasurerSell35,000.0013.19461,650.00438,267.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm
2018-07-02Sean A PowerCFO, Secretary and TreasurerSell12,191.0013.26161,652.66473,267.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm
2018-06-14WILLIAM JAMES KENNEDYDirectorSell25,071.0013.45337,204.9560,330.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418006742/0001654954-18-006742-index.htm
2020-07-16Sean A PowerCFO, Secretary and TreasurerBuy200,000.00633,338.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm
2020-06-22Sagar LonialDirectorBuy65,000.0065,000.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm
2018-06-26WILLIAM JAMES KENNEDYDirectorBuy15,000.0075,330.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007120/0001654954-18-007120-index.htm
2018-06-26DANIEL HUMEDirectorBuy15,000.0092,459.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007118/0001654954-18-007118-index.htm
2020-06-17WILLIAM JAMES KENNEDYDirectorSell7,745.0018.27141,501.1594,633.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm